Cargando…

Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care

BACKGROUND: The safety of restarting angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) after acute kidney injury (AKI) is unclear. There is concern that previous users do not restart ACEI/ARB despite ongoing indications. We sought to determine the risk of adve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bidulka, Patrick, Fu, Edouard L., Leyrat, Clémence, Kalogirou, Fotini, McAllister, Katherine S. L., Kingdon, Edward J., Mansfield, Kathryn E., Iwagami, Masao, Smeeth, Liam, Clase, Catherine M., Bhaskaran, Krishnan, van Diepen, Merel, Carrero, Juan-Jesus, Nitsch, Dorothea, Tomlinson, Laurie A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389346/ https://www.ncbi.nlm.nih.gov/pubmed/32723383 http://dx.doi.org/10.1186/s12916-020-01659-x

Ejemplares similares

Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study
por: Mansfield, Kathryn E, et al.
Publicado: (2016)

Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study
por: Bidulka, Patrick, et al.
Publicado: (2020)

Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin–angiotensin system blockers: a UK primary care cohort study
por: Sinnott, Sarah-Jo, et al.
Publicado: (2017)

Stopping versus continuing renin–angiotensin–system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data
por: Janse, Roemer J, et al.
Publicado: (2022)

Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study
por: Schmidt, Morten, et al.
Publicado: (2017)

Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin–angiotensin system blockade: a UK general practice-based cohort study
por: Schmidt, Morten, et al.
Publicado: (2017)

Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study
por: Crellin, Elizabeth, et al.
Publicado: (2018)

Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population‐based cohort study
por: Iwagami, Masao, et al.
Publicado: (2018)

Prevalence, incidence, indication, and choice of antidepressants in patients with and without chronic kidney disease: a matched cohort study in UK Clinical Practice Research Datalink
por: Iwagami, Masao, et al.
Publicado: (2017)

Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data
por: Iwagami, Masao, et al.
Publicado: (2018)

Diagnosis of acute kidney injury and its association with in-hospital mortality in patients with infective exacerbations of bronchiectasis: cohort study from a UK nationwide database
por: Iwagami, Masao, et al.
Publicado: (2016)

Severe mental illness and chronic kidney disease: a cross-sectional study in the United Kingdom
por: Iwagami, Masao, et al.
Publicado: (2018)

Paediatric acute kidney injury hospital admissions in England 1997–2014: burden and risk factors
por: Henderson, Alasdair, et al.
Publicado: (2019)

Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial
por: Baptiste, Paris J, et al.
Publicado: (2022)

The association between chronic kidney disease and tuberculosis; a comparative cohort study in England
por: Ruzangi, Judith, et al.
Publicado: (2020)

Acute kidney injury and infections in patients taking antihypertensive drugs: a self-controlled case series analysis
por: Mansfield, Kathryn E, et al.
Publicado: (2018)

Long-term effects of bariatric surgery on acute kidney injury: a propensity-matched cohort in the UK Clinical Practice Research Datalink
por: Koppe, Uwe, et al.
Publicado: (2018)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)

Association between chronic kidney disease and incident diagnosis of dementia in England: a cohort study in Clinical Practice Research Datalink
por: Hiramatsu, Rikako, et al.
Publicado: (2020)

Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom
por: Iwagami, Masao, et al.
Publicado: (2017)

COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients
por: Genet, Bastien, et al.
Publicado: (2020)

Kidney disease and mortality in patients with respiratory tract infections: a systematic review and meta-analysis
por: Su, Guobin, et al.
Publicado: (2020)

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
por: Mancia, Giuseppe, et al.
Publicado: (2020)

The risk of acute kidney injury in colorectal cancer survivors: an english population-based matched cohort study
por: Andresen, Kirsty, et al.
Publicado: (2023)

Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database
por: Bhaskaran, Krishnan, et al.
Publicado: (2012)

Association of Renin-Angiotensin System Blockers With Outcomes in Patients with COVID-19
por: Garg, Aakash, et al.
Publicado: (2020)

Association of Renin-Angiotensin System Blockers with Survival in Patients on Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

The importance of blood pressure thresholds versus predicted cardiovascular risk on subsequent rates of cardiovascular disease: a cohort study in English primary care
por: Herrett, Emily, et al.
Publicado: (2022)

Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink
por: Goh, Kah L, et al.
Publicado: (2015)

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors
por: Siragy, Helmy M
Publicado: (2011)

Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin‐angiotensin blockers
por: Heerspink, H. J. L., et al.
Publicado: (2016)

Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro
por: Caminhotto, R de O., et al.
Publicado: (2016)

Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2
por: Lévy, Bernard I., et al.
Publicado: (2020)

In reply— Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Impact of renin-angiotensin system inhibitors and beta-blockers on dental implant stability
por: Saravi, Babak, et al.
Publicado: (2021)

Impact of Renin‐Angiotensin System Blockers on Mortality in Veterans Undergoing Cardiac Surgery
por: Antoniak, Derrick T., et al.
Publicado: (2021)

Effect of renin-angiotensin system blocker on COVID-19 in young patients with hypertension
por: Kuzeytemiz, Mustafa, et al.
Publicado: (2022)

The comparative effectiveness of fourth‐line drugs in resistant hypertension: An application in electronic health record data
por: Sinnott, Sarah‐Jo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3alp8bd2mbptp1i4umdpk71flg